Pfizer Inc (PFE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2006 | 09-2006 | 06-2006 | 03-2006 | 12-2005 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,827,000 | 1,177,000 | 1,921,000 | 2,869,000 | 2,247,000 |
| Marketable Securities | 25,886,000 | 11,654,000 | 12,829,000 | 12,633,000 | 19,979,000 |
| Receivables | 9,392,000 | 9,177,000 | 9,275,000 | 10,352,000 | 9,103,000 |
| Inventories | 6,111,000 | 6,167,000 | 6,392,000 | 6,663,000 | 5,478,000 |
| Other current assets | 576,000 | 7,265,000 | 7,315,000 | 596,000 | 7,169,000 |
| TOTAL | $47,658,000 | $38,721,000 | $40,994,000 | $37,415,000 | $46,835,000 |
| Non-Current Assets | |||||
| PPE Net | 16,632,000 | 16,417,000 | 16,483,000 | 17,103,000 | 16,233,000 |
| Investments And Advances | 3,892,000 | 2,845,000 | 2,387,000 | 2,543,000 | 2,497,000 |
| Intangibles | 45,226,000 | 46,374,000 | 47,191,000 | 51,814,000 | 47,229,000 |
| Other Non-Current Assets | 2,138,000 | 4,228,000 | 4,495,000 | 4,084,000 | 4,176,000 |
| TOTAL | $67,888,000 | $69,864,000 | $70,556,000 | $75,544,000 | $70,135,000 |
| Total Assets | $115,546,000 | $108,585,000 | $111,550,000 | $112,959,000 | $116,970,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 2,434,000 | 2,508,000 | 3,779,000 | 5,059,000 | 11,589,000 |
| Accounts payable and accrued liabilities | 2,019,000 | 1,742,000 | 1,740,000 | 1,892,000 | 2,073,000 |
| Accrued Expenses | 1,903,000 | 1,533,000 | 1,399,000 | 1,504,000 | 1,602,000 |
| Other current liabilities | 6,512,000 | 5,271,000 | 5,655,000 | 7,719,000 | 6,521,000 |
| TOTAL | $22,099,000 | $17,688,000 | $20,055,000 | $19,674,000 | $28,402,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 5,546,000 | 5,561,000 | 5,450,000 | 6,508,000 | 6,347,000 |
| Other Non-Current Liabilities | 8,528,000 | 6,786,000 | 7,187,000 | 6,831,000 | 6,750,000 |
| TOTAL | $22,089,000 | $21,185,000 | $23,006,000 | $23,676,000 | $22,804,000 |
| Total Liabilities | $44,188,000 | $38,873,000 | $43,061,000 | $43,350,000 | $51,206,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 7,086,916 | 7,210,445 | 7,291,451 | 7,327,389 | 7,357,944 |
| Common Shares | 441,000 | 441,000 | 440,000 | 439,000 | 439,000 |
| Retained earnings | 49,669,000 | 43,991,000 | 40,627,000 | 41,715,000 | 37,608,000 |
| Other shareholders' equity | -1,116,000 | 671,000 | 960,000 | 281,000 | -275,000 |
| TOTAL | $71,358,000 | $69,712,000 | $68,489,000 | $69,609,000 | $65,764,000 |
| Total Liabilities And Equity | $115,546,000 | $108,585,000 | $111,550,000 | $112,959,000 | $116,970,000 |